Landmark trial may herald new era in HIV prevention.
rct · Level I
Where this comes from
- Record sourced from PubMed, PMID 39088634.
- Also identified by DOI 10.1126/science.ads1310.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Twice-yearly lenacapavir injections provide 100% protection in study in African women.
Medical subject headings
- Anti-HIV Agents
- HIV Infections
- Pre-Exposure Prophylaxis